ReviewImmunological reviews2017
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.
Bertrand Allard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
606 papers cite itlatest 60 shown
this papertrialcites it